To sell a medical device in the European Union (EU), manufacturers must obtain CE marking. This mark confirms that a device meets the EU’s essential safety, health, and performance standards, allowing it to be marketed throughout the EU and European Economic Area (EEA) without additional approvals.
The CE marking process is detailed and highly regulated. Companies must prepare comprehensive technical documentation, demonstrate clinical safety, comply with multilingual labeling requirements, and follow strict ongoing surveillance once the product is on the market. Under the current Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), these expectations are more rigorous than ever.
This guide provides a clear, structured overview of what CE marking involves and how manufacturers can approach each stage effectively. It is designed to help you understand the requirements early, reduce compliance challenges, and ensure a smooth route to the EU market.
What Is CE Marking for Medical Devices?
CE marking (Conformité Européenne) is a regulatory symbol placed on a medical device to confirm that it complies with the European Union’s safety and performance laws, specifically the Medical Device Regulation (EU MDR 2017/745) and the In Vitro Diagnostic Regulation (IVDR 2017/746). Once a device has earned this mark, it can be sold throughout the EU and EEA without additional national approvals.
What Does CE Marking Represent?
- The device meets all General Safety and Performance Requirements (GSPRs).
- The product has undergone the correct conformity assessment for its risk classification.
- The manufacturer takes full legal responsibility for the device’s safety, quality, and intended use.
- The device can be freely circulated and sold within the EU and EEA markets.
Note that the CE mark is not a quality mark in the traditional marketing sense. Instead, it is a regulatory declaration that the product performs as intended and does not pose unacceptable risks to users.
Why Language Matters in Compliance
One of the most demanding aspects of CE compliance is language and labeling. To protect users across a multilingual region, the EU requires:
- Complaint labeling
- Instructions for Use (IFUs)
- Warnings, safety information, and UDI codes
- All translated into the official language(s) of every EU country where the device is sold
A device tested to the highest standards will still fail compliance if patients cannot read the safety information in their own language. For global companies, this makes precise, regulatory-aligned translation and localization essential, particularly for safety-critical content.
What Are the CE Marking Requirements for Medical Devices?
Before starting the CE approval journey, manufacturers must establish compliance in six core areas:
1. Device Classification
Devices must be classified by risk:
- Class I: low risk, usually self-certified
- Class IIa and IIb: medium risk, Notified Body involvement required
- Class III: high risk, intensive assessment and clinical evidence required
The higher the risk, the more rigorous the conformity assessment and the greater the involvement needed from a Notified Body.
2. General Safety and Performance Requirements (GSPRs)
Manufacturers must demonstrate that the device meets all GSPRs outlined in Annex I of the MDR. These requirements ensure a safe design, an acceptable risk-benefit balance, biological and chemical safety, infection control, and accurate information supplied with the device. All supporting evidence must be clearly documented in the technical file.
3. Technical Documentation
A complete technical file must be prepared to demonstrate conformity. It should include:
- Device description and intended use
- Design and manufacturing information
- Risk management documentation
- Clinical evaluation reports
- Usability and safety test results
- Labeling, IFUs, and UDI details
- Post-market surveillance planning
For devices above Class I, this documentation is reviewed by a Notified Body.
4. Clinical Evidence
Manufacturers must provide clinical data that proves the device is safe and effective for its intended purpose. Higher-risk devices require stronger clinical evidence.
Clinical evaluation is a continuous activity that must be updated as new data emerges.
5. Quality Management System (QMS)
A documented QMS must be in place to control manufacturing, supplier management, complaint handling, and post-market activities. ISO 13485 is the recognised standard for demonstrating QMS compliance and is commonly audited by Notified Bodies.
6. Language and Labeling Compliance
All labeling, Instructions for Use, safety information, and UDI identifiers must be provided in the official language of every EU country where the device is sold. Accurate and consistent medical device translation is essential to avoid compliance failures, delays, and safety risks.
Step-by-Step Guide to Obtaining CE Marking
Below is a structured roadmap manufacturers can follow:
1. Determine Your Device Classification
Classify your device using Annex VIII of the MDR. Risk classification defines the approval pathway:
- Class I: Low risk (corrective glasses, non-invasive instruments).
- Class IIa: Medium risk (hearing aids, contact lenses)
- Class IIb: Medium-to-high risk (incubators, long-term implants).
- Class III: High risk (pacemakers, heart valves).
2. Identify Applicable Regulatory Requirements
Once classified, identify the specific MDR GSPRs applicable to your device. You should also identify any “harmonized standards” for design, testing, and risk management. Early regulatory planning reduces delays later in the process.
3. Conduct a Clinical Evaluation
Clinical evaluation must demonstrate that the device performs as intended without compromising patient safety. This is documented in a Clinical Evaluation Report (CER).
This may involve:
- Literature review for well-established technologies
- Clinical investigations for higher-risk or innovative devices
The CER must be continuously updated with new clinical data once the device is on the market.
4. Prepare Technical Documentation
Compile a complete and well-organized technical file containing:
- Device description and intended use
- Design and manufacturing information
- Risk management files
- Verification and validation data
- Labeling, IFUs, and UDI details
- Post-market surveillance planning
All documents must be clear and traceable for regulatory review.
5. Implement a Quality Management System (QMS)
Your QMS must manage design control, manufacturing processes, suppliers, complaint handling, and post-market activities. ISO 13485 is the most commonly used standard for demonstrating compliance and is evaluated during audits.
6. Work with a Notified Body (If Required)
Devices above Class I require an independent assessment by a Notified Body.
The Notified Body will:
- Review your technical documentation
- Audit your QMS
- Ask questions and request clarifications where needed
Once satisfied, it issues the CE Certificate that allows you to proceed.
7. Create the EU Declaration of Conformity
The Declaration of Conformity (DoC) is a signed legal document that confirms that the device meets all applicable EU requirements. It must be based on valid evidence and kept available for authorities at all times.
8. Affix the CE Marking and Maintain Compliance
Place the CE symbol on the device, packaging, and supplied documents, including the Notified Body number when required.
Ongoing responsibilities include:
- Post-market surveillance
- Continuous clinical evaluation updates
- Timely reporting of incidents to Competent Authorities
CE marking is not a one-time approval. Compliance must be monitored throughout the device’s lifecycle.
Conclusion
Securing CE marking for medical devices is essential for EU market access. It requires a clear understanding of risk classification, strong technical and clinical documentation, and multilingual labeling that meets each country’s safety requirements.
Following a structured process helps reduce delays and strengthens confidence in product safety and performance. Accurate files, clear instructions, and consistent translations are key to smooth approval and ongoing compliance.
EC Innovations supports manufacturers with expert regulatory translation and localization services for labeling, IFUs, technical documentation, and clinical content. Contact us to ensure your CE compliance requirements are met confidently and efficiently.
